ALXO ALX Oncology Holdings Inc.
Healthcare$1.93-2.53%ClosedMarket Cap: $104.7M
As of 2026-05-26
Valuation
P/E (TTM)
—
PEG
—
P/B
0.71
P/S
0.00
EV/EBITDA
-0.91
DCF Value
$0.13
FCF Yield
-73.0%
Div Yield
0.0%
Margins & Returns
Gross Margin
0.0%
Operating Margin
0.0%
Net Margin
0.0%
ROE
-124.1%
ROA
-49.8%
ROIC
-55.8%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $0.00 | -Infinity% | $-19.0M | $-17.9M | $— | — |
| Q4 null | $0.00 | NaN% | $-23.0M | $-22.8M | $— | — |
| FY null | $0.00 | NaN% | $-104.0M | $-101.7M | $— | — |
| Q3 null | $0.00 | NaN% | $-22.5M | $-22.1M | $— | — |
| Q2 null | $0.00 | NaN% | $-26.6M | $-25.9M | $— | — |
| Q1 null | $0.00 | NaN% | $-31.8M | $-30.8M | $— | — |
| Q4 null | $0.00 | NaN% | $-30.6M | $-29.2M | $— | — |
| FY null | $0.00 | NaN% | $-142.5M | $-134.8M | $— | — |
| Q3 null | $0.00 | NaN% | $-32.6M | $-30.7M | $— | — |
| Q2 null | $0.00 | -Infinity% | $-41.5M | $-39.4M | $— | — |
| Q1 null | $0.00 | -Infinity% | $-37.8M | $-35.6M | $— | — |
| Q4 2023 | $0.00 | NaN% | $-48.0M | $-45.5M | $-0.93 | — |